Development of ABR peer review External Quality Assurance system
key details
| Status | complete |
|---|---|
| Procedure | direct |
| SME suitable | Yes |
| OCID | ocds-h6vhtk-060d52 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| GENQA LTD | £280,000 | 3 Sept 2025 | active |
description
Development of a standard rapid Auditory Brainstem Response External Quality Assurance (ABR EQA) scheme focused on ABR traces only in partnership with Gen QA (consortium with NEQAS and the National Physical Laboratory), to facilitate national and regional ABR EQA and provide an improved measure and assurance of testing performance.
The recent review into paediatric audiology within England has shown a significant gap in ABR testing, both in terms of knowledge in performing the test and in quality assurance of the testing. At the present time, the only form of quality assurance for ABR testing is through peer review. There is no national external quality assessment scheme. ABR peer review, is sporadic across the country, with a number of different groups across each area. The quality of these groups is variable, with differing governance structures and no consistent criteria for which cases are selected for review. Participation, desp
notice history
6 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 4 Sept 2025 | Contract award notice (F03) | Earlier regulations | 053791-2025 |
| 4 Sept 2025 | Award (award) | · | 92f9581f-a563-4b43-92eb-b440d2905d2d-862103 |
| 23 Jan 2026 | Transparency notice (UK5) | Procurement Act 2023 | 006185-2026 |
| 23 Jan 2026 | Contract award (UK6) | Procurement Act 2023 | 006189-2026 |
| 12 Jun 2026 | Contract details (UK7) | Procurement Act 2023 | 055831-2026 |
| 15 Jun 2026 | Contract termination (UK11) | Procurement Act 2023 | 056157-2026 |
more from NHS England
- Exam Support Packages for EoE GP Registrars · £72,673 · 24 Jul 2026
- Refer a Patient - Adult ECMO 2026/27 · £99,362 · 23 Jul 2026
- Higher Specialist Scientist Training Programme (HSST) · £42,186,231 · 23 Jul 2026
- Imaging National Lecture Series · £400,000 · 22 Jul 2026
- NHS National Framework for Lenvatinib · £35,833,000 · 22 Jul 2026
- The Practice Education Facilitator role in Return to Practice · £20,000 · 22 Jul 2026
- Pharmacy Technician Clinical Skills Development · £300,000 · 22 Jul 2026
- NHS National Framework for Ferric Carboxymaltose injection · £62,633,000 · 21 Jul 2026
all contracts from this buyer →
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.